Not Tagged
Not Tagged
['cll']
dr. gayathri ravi presents a potential model for an mrd-adapted discontinuation of therapy pathway in asct-eligible ndmm patients . #ash22 clonoseq is fda-cleared to assess mrd in cll, mm and b-all. for further info: 
The FDA-cleared clonoSEQ Assay from @AdaptiveBiotech detects and tracks MRD in patients w/ myeloma, B-ALL, or CLL. Policies: https://t.co/6zaCbi4pmE.